Interview with Vancouver’s The Tyee on antibody-based therapy for COVID-19

Vancouver biotech company AbCellera is developing antibodies to treat COVID-19. In the six-minute video below from The Tyee, Ralph Pantophlet is interviewed alongside Véronique Lecault, COO of AbCellera. They explain what antibody treatment is and endeavors to apply it to COVID-19. The video also explains how advances in technology are helping to find and isolate the right antibodies.